These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 17035257)

  • 1. Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings.
    Piacentino D; Sani G; Kotzalidis GD; Cappelletti S; Longo L; Rizzato S; Fabi F; Frati P; Fineschi V; Leggio L
    Hum Psychopharmacol; 2022 Jan; 37(1):e2815. PubMed ID: 34528289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the Self: Amateur Bodybuilders Making Sense of Experiences With Appearance and Performance-Enhancing Drugs.
    Macho J; Mudrak J; Slepicka P
    Front Psychol; 2021; 12():648467. PubMed ID: 34177704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggression and Psychological Distress in Male and Female Anabolic-Androgenic Steroid Users: A Multigroup Latent Class Analysis.
    Chegeni R; Notelaers G; Pallesen S; Sagoe D
    Front Psychiatry; 2021; 12():629428. PubMed ID: 34149470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Men´s experiences of using anabolic androgenic steroids.
    Börjesson A; Ekebergh M; Dahl ML; Ekström L; Lehtihet M; Vicente V
    Int J Qual Stud Health Well-being; 2021 Dec; 16(1):1927490. PubMed ID: 34006211
    [No Abstract]   [Full Text] [Related]  

  • 5. The Impact of the COVID-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids.
    Zoob Carter BN; Boardley ID; van de Ven K
    Front Psychiatry; 2021; 12():636706. PubMed ID: 33828494
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men.
    Bonnecaze AK; O'Connor T; Aloi JA
    Am J Mens Health; 2020; 14(6):1557988320966536. PubMed ID: 33307930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment.
    Havnes IA; Jørstad ML; McVeigh J; Van Hout MC; Bjørnebekk A
    Subst Abuse; 2020; 14():1178221820904150. PubMed ID: 32127749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between muscle dysmorphia and eating disorder symptomatology: A systematic review and meta-analysis.
    Badenes-Ribera L; Rubio-Aparicio M; Sánchez-Meca J; Fabris MA; Longobardi C
    J Behav Addict; 2019 Sep; 8(3):351-371. PubMed ID: 31505966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access.
    Harvey O; Keen S; Parrish M; van Teijlingen E
    BMC Public Health; 2019 Jul; 19(1):1024. PubMed ID: 31366349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a Sustainable Nutrition Paradigm in Physique Sport: A Narrative Review.
    Helms ER; Prnjak K; Linardon J
    Sports (Basel); 2019 Jul; 7(7):. PubMed ID: 31315180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual orientation, bullying for being labeled gay or bisexual, and steroid use among US adolescent boys.
    Parent MC; Bradstreet TC
    J Health Psychol; 2018 Mar; 23(4):608-617. PubMed ID: 28810404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study.
    Kimergård A; McVeigh J
    Harm Reduct J; 2014 Jul; 11():19. PubMed ID: 24986546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research.
    Sagoe D; Andreassen CS; Pallesen S
    Subst Abuse Treat Prev Policy; 2014 Jul; 9():27. PubMed ID: 24984881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK.
    Kimergård A; McVeigh J
    BMJ Open; 2014 Jun; 4(6):e005275. PubMed ID: 24898090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of a figure rating scale assessing body size perception in school-age children.
    Lombardo C; Battagliese G; Pezzuti L; Lucidi F
    Eat Weight Disord; 2014; 19(3):329-36. PubMed ID: 24264145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports.
    Skårberg K; Nyberg F; Engström I
    Subst Abuse Treat Prev Policy; 2008 Nov; 3():24. PubMed ID: 19040748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences of anabolic steroid use: in-depth interviews with men and women body builders.
    Grogan S; Shepherd S; Evans R; Wright S; Hunter G
    J Health Psychol; 2006 Nov; 11(6):845-56. PubMed ID: 17035257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic androgenic steroids: a survey of 500 users.
    Parkinson AB; Evans NA
    Med Sci Sports Exerc; 2006 Apr; 38(4):644-51. PubMed ID: 16679978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social capital: implications from an investigation of illegal anabolic steroid networks.
    Maycock BR; Howat P
    Health Educ Res; 2007 Dec; 22(6):854-63. PubMed ID: 17584951
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.